SCHEMBL10080353

SCHEMBL10080353

Nc1cc(-c2ccnc(Cl)n2)ccc1N1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 3/20 0.54
CDC7 O00311 1/20 0.49
ROCK2 O75116 1/20 0.49
MAP4K4 O95819 1/20 0.49
CDK2 P24941 1/20 0.49
GSK3B P49841 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
IRAK4 Q9NWZ3 1/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 3/20 0.46
S100B P04271 1/20 0.44
POLB P06746 3/20 0.41
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8042384 0.87 ALDH1A1 (0.49) KMOCDC7ROCK2MAP4K4CDK2
SCHEMBL435611 0.82 KMO (0.52) KMOCDC7ROCK2MAP4K4CDK2
SCHEMBL12801571 0.78 KMO (0.51) KMOMAP4K4CDK2ALDH1A1TDP1
SCHEMBL23850712 0.74 HDAC3 (0.52) CDC7ROCK2MAP4K4CDK2GSK3B
SCHEMBL3761043 0.74 CAMK2D (0.64) KMOCAMK2D
SCHEMBL23850971 0.71 S100B (0.49) CDC7ROCK2MAP4K4CDK2GSK3B
SCHEMBL23850847 0.71 S100B (0.49) CDC7ROCK2MAP4K4CDK2GSK3B
SCHEMBL16990762 0.71 ROCK2 (0.59) KMOCDC7ROCK2MAP4K4CDK2
SCHEMBL10080361 0.71 CCNA2 (0.47) CDK2GSK3BCLK4
SCHEMBL12801634 0.70 KMO (0.50) KMOCDK2CLK4ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013024282-A2 COMPOUNDS AND THEIR USES DOMAINEX LIMITED (GB) 2013-02-21 WO disclosed
WO-2012010826-A1 PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES IKK EPSILON AND/OR TBK-1, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMAINEX LIMITED (GB) 2012-01-26 WO disclosed